Neoadjuvant chemotherapy with trastuzumab or lapatinib: Survival analysis of the HER2-positive cohort of the GeparQuinto study (GBG 44)

Date 26 September 2015
Event European Cancer Congress 2015
Session Breast Cancer - Advanced Disease
Topics Breast Cancer, Metastatic
Presenter Untch, M.